Disruptive Pharma AB

📍 Stockholm, Sweden🗓 Founded 2021👥 18 employees💰 Last funded Apr 2024
Disruptive Pharma is a pharmaceutical company that develops novel drug products by applying a unique drug delivery technology. We develop selected drug products based on our proprietary drug delivery platform, the pharma-grade mesoporous magnesium carbonate (Pharma-MMC). The Disruptive Pharma company has offices in both Uppsala (HQ) and Stockholm. By a clever combination of already approved active pharmaceutical ingredients (APIs) with Pharma-MMC platform, several unique opportunities to realize highly valuable therapeutically equivalent or improved drug products emerges. The Pharma-MMC drug delivery technology can be used to create amorphous solid dispersions of the drug, hence increasing its dissolution and the body’s ability to absorb the drug, and may be used to rescue particularly difficult drugs or to enable novel product formulations Disruptive Pharma is a spin-out from the company Disruptive Materials that is located in Uppsala. The company is well-positioned to exploit its pioneering discovery of a unique mesoporous magnesium carbonate (MMC) material. Up until breakthrough discovery by the group of Professor Maria Strømme in 2012, commercialized by Disruptive Materials AB in 2013.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Disruptive Pharma AB?
Disruptive Pharma AB has 1 investors on record on gritt.io, 1 mid-stage.
When did Disruptive Pharma AB last raise funding?
The most recent investment in Disruptive Pharma AB recorded on gritt.io was in April 2024.
When was Disruptive Pharma AB founded?
Disruptive Pharma AB was founded in 2021.
What industry is Disruptive Pharma AB in?
Disruptive Pharma AB operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Disruptive Pharma AB based?
Disruptive Pharma AB is headquartered in Stockholm, Sweden.